184 related articles for article (PubMed ID: 793705)
1. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
Taylor HE; Ackman CF; Horowitz I
Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705
[TBL] [Abstract][Full Text] [Related]
2. Antilymphocyte globulin in cadaveric renal transplantation--a controlled trial.
Jakobsen A; Sødal G; Flatmark A; Thorsby E
Scand J Urol Nephrol Suppl; 1977; (42):94-6. PubMed ID: 356233
[TBL] [Abstract][Full Text] [Related]
3. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function.
Matas AJ; Tellis VA; Quinn TA; Glicklich D; Soberman R; Veith FJ
Transplantation; 1988 Feb; 45(2):406-9. PubMed ID: 3278434
[TBL] [Abstract][Full Text] [Related]
4. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants.
Sansom JR; Barnes AD; Hall CL
Postgrad Med J; 1976; 52(5 Suppl):75-8. PubMed ID: 792851
[TBL] [Abstract][Full Text] [Related]
5. The use of antilymphocyte globulin in renal allograft rejection. A controlled study.
Birkeland SA
Postgrad Med J; 1976; 52(5 Suppl):82-8. PubMed ID: 792853
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
[TBL] [Abstract][Full Text] [Related]
7. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
[TBL] [Abstract][Full Text] [Related]
8. Acute rejection episodes after renal transplantation in children.
Hoyer PF; Offner G; Brodehl J
Clin Nephrol; 1983 Feb; 19(2):61-6. PubMed ID: 6340876
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with antilymphocyte-globulin in cadaveric kidney transplantation.
Ahlmen J; Storm B; Brynger H; Sandberg L; Gelin LE
Scand J Urol Nephrol Suppl; 1977; (42):90-3. PubMed ID: 356232
[TBL] [Abstract][Full Text] [Related]
10. Controlled trial of antilymphocyte globulin in cadaveric transplantation.
Jakobsen J; Flatmark A; Sodal G; Thorsby E
Postgrad Med J; 1976; 52(5 Suppl):72-4. PubMed ID: 792850
[TBL] [Abstract][Full Text] [Related]
11. Alternative antirejection treatment with steroids or antilymphoblast globulin in renal transplant patients receiving cyclosporine.
Veremis SA; Maddux MS; Pollak R; Kline SS; Mozes MF
Transplant Proc; 1987 Feb; 19(1 Pt 3):1893-5. PubMed ID: 3079056
[TBL] [Abstract][Full Text] [Related]
12. Antilymphocyte globulin and renal transplantation.
Tagnon A
Postgrad Med J; 1976; 52(5 Suppl):64-6. PubMed ID: 792848
[TBL] [Abstract][Full Text] [Related]
13. Improved results in high risk cadaveric kidney transplantation.
Toledo-Pereyra LH; Baskin S; McNichol L; Edford G; Whitten J; Allaben R
Proc Clin Dial Transplant Forum; 1980; 10():289-92. PubMed ID: 7050990
[TBL] [Abstract][Full Text] [Related]
14. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
Boratyńska M; Szepietowski T; Szewczyk Z; Szydłowski Z
Arch Immunol Ther Exp (Warsz); 1992; 40(2):163-8. PubMed ID: 1299176
[TBL] [Abstract][Full Text] [Related]
15. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin.
Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D
Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568
[TBL] [Abstract][Full Text] [Related]
16. New experiences with antilymphocyte globulin in human organ transplantation.
Largiadér F; Ruckert R
Postgrad Med J; 1976; 52(5 Suppl):79-81. PubMed ID: 792852
[TBL] [Abstract][Full Text] [Related]
17. Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts.
Putnam CW; Bell RH; Beart RW; Anderson JT; Weil R
Postgrad Med J; 1976; 52(5 Suppl):59-63. PubMed ID: 792847
[TBL] [Abstract][Full Text] [Related]
18. Experience with antilymphocyte globulin in 144 renal transplant recipients.
Lundgren G; Collste L; Groth CG; Krzymansky M; Magnusson G; Quadracci L; Ringdén O; Svehag SE
Postgrad Med J; 1976; 52(5 Suppl):67-71. PubMed ID: 792849
[TBL] [Abstract][Full Text] [Related]
19. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine.
Halloran PF; Aprile MA; Farewell V; Ludwin D; Smith EK; Tsai SY; Bear RA; Cole EH; Fenton SS; Cattran DC
Transplantation; 1988 Aug; 46(2):223-8. PubMed ID: 3043779
[TBL] [Abstract][Full Text] [Related]
20. An analysis of predictors of long-term cadaveric renal allograft survival.
Cole E; Naimark D; Aprile M; Wade J; Cattran D; Pei Y; Fenton S; Robinette M; Zaltsman J; Bear R
Clin Transplant; 1995 Aug; 9(4):282-8. PubMed ID: 7579734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
